The effect of feto-maternal blood type incompatibility on development of gestational diabetes mellitus

dc.authorid0000-0001-5642-6498
dc.authorid0000-0002-7361-8181
dc.authorid0000-0002-2519-5989
dc.authorid0000-0001-7778-1114
dc.authorid0000-0001-7281-5477
dc.contributor.authorKanat, Mustafa
dc.contributor.authorGöksügür, Sevil Bilir
dc.contributor.authorÖzlü, Tülay
dc.contributor.authorTunçkale, Aydın
dc.contributor.authorÖztürk, B.
dc.contributor.authorKaragöz, Yalçın
dc.date.accessioned2021-06-23T18:55:38Z
dc.date.available2021-06-23T18:55:38Z
dc.date.issued2014
dc.departmentBAİBÜ, İktisadi ve İdari Bilimler Fakültesi, İşletme Bölümüen_US
dc.description.abstractObjective. To assess the relation between fetal and maternal blood type (ABO, Rh) incompatibility and development of gestational diabetes mellitus (GDM). Materials and Methods. A total of 500 pregnant women underwent diagnostic test for GDM by a 100-g oral glucose tolerance test (OGTT) after an 8 to 12-h overnight fast participated in this study. OGTT was performed between the 24-28 weeks of gestation, but participants who were at high risk for GDM were tested after the first prenatal visit. In the postpartum period, maternal and infant blood types were determined. Presence of GDM was evaluated in terms of matched and unmatched fetal and maternal ABO and Rh blood types separately. Results. GDM was detected in 235 participants. Unmatched ABO blood types between the mother-infant pairs were present in 44.7% (n=105) of GDM (+) and 35.8 % (n=95) of GDM (-) patients. Incompatible feto-maternal ABO blood type was positively correlated with development of GDM which was marginally significant. (p=0.045; R=1.2;95% CL; 1.004-1.48). However, Rh feto-maternal blood type incompatibility was not related with development of GDM. Conclusions. Feto-maternal ABO blood type incompatibility may be a weak risk factor for the development of GDM. © Società Editrice Universo (SEU).en_US
dc.identifier.doi10.7471/CT.2014.1698
dc.identifier.endpagee147en_US
dc.identifier.issn0009-9074
dc.identifier.issue2en_US
dc.identifier.pmid24770823en_US
dc.identifier.scopus2-s2.0-84899759696en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpagee145en_US
dc.identifier.urihttps://doi.org/10.7471/CT.2014.1698
dc.identifier.urihttps://hdl.handle.net/20.500.12491/4823
dc.identifier.volume165en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorGöksügür, Sevil Bilir
dc.institutionauthorÖzlü, Tülay
dc.institutionauthorKaragöz, Yalçın
dc.language.isoenen_US
dc.publisherSocieta Editrice Universoen_US
dc.relation.ispartofClinica Terapeuticaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectABO Blood Typeen_US
dc.subjectGestational Diabetes Mellitusen_US
dc.subjectRh Blood Typeen_US
dc.titleThe effect of feto-maternal blood type incompatibility on development of gestational diabetes mellitusen_US
dc.typeArticleen_US

Dosyalar